Health & Biotech
Biohacking is more popular than ever, but how healthy is the fixation on longevity?
‘Time is brain’: EMVision clocks key milestones in big year for its portable stroke-diagnostic tech
Health Check: It’s all the way in the USA as ASX medtechs ramp up in Trumpland
Health Food Symmetry eyes public debut with $2 million raise to shake up gut health market
From Petri dishes to pharma giants, Clever Culture’s AI goes global
ReNerve builds momentum with expanded NervAlign nerve repair study
Orthocell appoints second Canadian distributor for flagship nerve repair device
Imagion collaboration with Wayne Street University yields positive results
Health Check: Our flu recovery prognosis is positive, CSL tells investors
ASX Health Quarterly Wrap: Progress on multiple fronts in strong start to FY26
ASX Health October Winners: When CSL sneezes, sector catches flu
Biocurious: Buoyed by capital raisings, biotechs storm home with a wet sail
Health Check: Biotechs canter into November, but the ‘favourites’ have lead in their saddlebags
ASX Quarterly Medtech Wrap: Strong growth, fresh capital and key milestones
Dr Boreham’s Crucible: Nova Eye’s US vision sharpens as profits come into view
Bright start: Orthocell shines with first Remplir surgery in Hong Kong
Health Check: Despite selling life-saving tech, Uscom faces its honourable demise
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
